3
Announcements
Trials
Browse
Landscape
Status
Unknown
1
Sponsor Class
OTHER
7
INDUSTRY
6
UNKNOWN
1
Study Type
Observational
1
Sponsor
Cancer Type
Breast
1
Conditions
Hormone Receptor Positive Advanced Breast Cancer
1
Interventions
palbociclib
2
Fulvestrant
2
pembrolizumab
1
niraparib
1
exemestane
1
Therapeutics
1
Standard of Care
1
Radiotherapy, Adjuvant
1
Radiation
1
Pharmaceutical Preparations
1
Neoadjuvant Therapy
1
Methods
1
Letrozole
1
Immunotherapy
1
Aromatase Inhibitors
1
Anastrozole
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
UNKNOWN
×
Observational
×
Aromatase Inhibitors
×
Clear all
NCT05000736
2022-04-29
CAPACITY
ChineseAMS
Unknown
600 enrolled